Bart Van Vooren
is a partner in Covington & Burling LLP’s Brussels office. He has a broad regulatory practice under EU and national laws, advising pharmaceutical, food, biotech and device companies. Significant experience includes orphan medicines, ATMPs, advertising, regulatory exclusivities and transparency issues. He has handled more than three dozen cases before the EU Court of Justice. He is a leading global expert on life sciences companies’ compliance with the Biodiversity Convention and the Nagoya Protocol. Bart regularly writes and speaks on life sciences issues, and has written several handbooks on EU law.
Chambers and Partners make no representation or endorsement of the quality and services supplied
by companies or firms that may be found on this website. In no event will Chambers and Partners
be liable for any damages including, without limitation, indirect or consequential damages,
or any damages whatsoever arising from use or loss of use, data, or profits, whether in action
of contract, negligence or other tort action, arising out of or in connection with the use
of the website.